Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Ovarian Neoplasms × Interferon alpha-2 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 20 Carcinoma, Renal Cell 16 HIV Infections 6 Acquired Immunodeficiency Syndrome 6 Sarcoma, Kaposi 5 Leukemia 5 Neoplasm Metastasis 4 Lymphoma 4 Triple Negative Breast Neoplasms 3 Recurrence 3 Neoplasms 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Kidney Neoplasms 3 Hematologic Neoplasms 3 Pancreatic Neoplasms 2 Mycosis Fungoides 2 Multiple Myeloma 2 Leukemia, Myeloid, Chronic-Phase 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Brain Neoplasms 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Tumor Virus Infections 1 Thrombocythemia, Essential 1 Solid Cancers 1 Skin Neoplasms 1 Prostatic Neoplasms 1

Interventions

Carboplatin 286 Paclitaxel 283 Bevacizumab 149 pembrolizumab 94 Gemcitabine 87 liposomal doxorubicin 86 Cyclophosphamide 83 Cisplatin 79 olaparib 77 Topotecan 77 niraparib 57 Docetaxel 51 Doxorubicin 46 Taxes 41 Drug Therapy 38 fludarabine 36 Nivolumab 34 Filgrastim 32 Specimen Handling 28 Etoposide 28 Magnetic Resonance Spectroscopy 26 durvalumab 23 Peripheral Blood Stem Cell Transplantation 23 Immunoglobulin G 23 Disulfides 23 Hyperthermic Intraperitoneal Chemotherapy 22 Albumin-Bound Paclitaxel 22 aldesleukin 20 Biopsy 20 atezolizumab 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01639885 2014-01-07

CHIP

Leiden University Medical Center

Phase 1/2 Completed

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡